STARLIMS Clinical LIMS and Clinisys GLIMS are not interchangeable entries in the same procurement category. STARLIMS positions its Clinical LIMS as part of a broader clinical informatics platform that includes ELN, LES, SDMS, and analytics, with documentation emphasizing specimen lifecycle management, workflow configuration, and compliance support across clinical, clinical trial, and biorepository settings [1][3][7]. Clinisys describes GLIMS as a laboratory information system organized around order entry, instrument control, results reporting, invoicing, and statistics, with dedicated genetics and HLA transplant modules [9]. The practical comparison therefore turns less on a single feature list and more on which documented workflow and organizational setting each vendor describes. This article maps those boundaries using vendor-published materials, attributes claims by name, and identifies unresolved questions that a buyer would need to resolve through direct vendor inquiry.

Documented Workflow Boundaries

STARLIMS describes its Clinical LIMS as covering specimen collection, receiving, testing, processing, storage location management, querying, and referral [1]. The vendor states that users can manage chain of custody with electronic signatures, customer billing, and invoicing for specimen shipping, processing, and testing [1]. A separate clinical LIMS page adds barcode scan fields, graphical tools, query functions, chronological specimen history, home locations, due dates for return, and responsible individuals [2]. STARLIMS also states that the system can interface with automated specimen handling systems, analytical instruments, system-to-system communications, and direct database communications [2]. These statements describe a specimen-centric workflow that extends from accessioning through storage and referral.

Clinisys describes GLIMS as covering order entry, instrument control, results reporting, invoicing, and statistics [9]. The vendor states that GLIMS can be used across private, hospital, specialist, and university laboratories, and lists haematology, clinical chemistry, and serology among supported disciplines [9]. Clinisys also describes a task-oriented .NET-based user interface and a Business Activity Monitor for management dashboards [9]. The documented workflow emphasis is patient-centric and discipline-based, with invoicing and statistics presented as core functions rather than add-ons. Neither vendor's public material provides a side-by-side workflow map, so the exact overlap between STARLIMS specimen lifecycle functions and GLIMS order-to-report functions remains a point for direct vendor clarification.

Module and Edition Scope

STARLIMS presents its Clinical LIMS within a Clinical Informatics Platform that also includes Labstep ELN, LES, SDMS, and Advanced Analytics [1][8]. The vendor states that the platform integrates these components to provide a consolidated view of lab operations [8]. A clinical solution brochure lists microbiology, immunology plate-based testing, clinical genetics and molecular biology, quality control management, reporting, SDMS, and material management as documented areas [6]. STARLIMS also describes mobile applications, rules manager, and advanced analytics as part of the clinical solution [6]. These materials describe a broad platform scope, but they do not specify which components are included by default versus sold separately.

Clinisys documents GLIMS Genetics Module and GLIMS HLA Transplant as modules that provide extra features used only for genetics-specific or HLA-specific disciplines [9][10]. The vendor states that the Genetics Module can work as a standalone solution or interface with LIS from other disciplines, and can also be configured as part of a complete diagnostics LIS such as GLIMS [10]. Clinisys describes support for PCR, RT-PCR, Sanger sequencing, NGS, FISH, karyotype, and microarray within the Genetics Module [10]. The HLA Transplant Module is described as covering high-resolution typing and screening and integration with national organ donation databases [9]. These module descriptions are more granular than STARLIMS's public clinical brochure, but the two vendors organize their offerings differently, making direct module-to-module comparison difficult.

A Suggested Evaluation Workflow for a Multi-Discipline Hospital Laboratory

A hospital laboratory evaluating both products could document a single patient order that moves through chemistry, haematology, and molecular genetics. For STARLIMS, the evaluation would ask how the Clinical LIMS workflow engine handles order routing across those disciplines and whether the clinical genetics functions described in the brochure require separate configuration [4][6]. For GLIMS, the evaluation would ask whether the Genetics Module must be licensed separately and how it interfaces with the core LIS disciplines [9][10]. This scenario is a suggested exercise, not a documented customer implementation.

The same laboratory could then compare how each vendor documents instrument connectivity and results reporting. STARLIMS materials describe interfaces to analytical instruments and HL7 web-based reports [2][6]. Clinisys materials describe instrument control as a core GLIMS function and list numerous instrument and EHR interfaces [9][11]. A buyer would need to confirm which specific instruments and EHR versions are supported in the current release, since the retrieved interface lists do not include version or date information for every entry.

Technical Documentation and Release Information

STARLIMS publishes release notes for Life Sciences versions. A May 2025 announcement describes LS 11.4 and LES 1.4, including workflow engine configuration for multiple step outputs from a single step input, sample reception enhancements for clinical, clinical trial, and biorepository shipments, API or eManifest file uploads, and static data import from CSV or Excel [7]. An October 2025 announcement describes LS 11.5 for Clinical Labs, including turnaround time configuration at test and workflow step levels, rule-based sample routing, Edit Run for result correction with traceability, and streamlined LOINC import [4]. These release notes provide specific technical detail about configuration capabilities and version numbering.

Clinisys provides less version-specific technical documentation in the retrieved materials. The vendor states that GLIMS uses a .NET-based user interface and describes successful passage of all tests at the 2009, 2010, 2012, and 2019 IHE Connectathons [9]. Clinisys also publishes an interfaces and system integration page listing HL7 protocols and numerous EHR, reference lab, and instrument interfaces [11]. The vendor describes an expert integration team and states that host system, billing, outreach, interface engine, blood bank, instrument, and reference lab interfaces have become routine [11]. Unlike STARLIMS, Clinisys does not provide dated GLIMS release notes in the retrieved sources, leaving the current GLIMS version and recent feature changes unresolved.

Customer Segment Differences

STARLIMS describes its Clinical LIMS for patient care, disease detection, and medical research, and states that the platform supports clinical, clinical trial, and biorepository sample shipments [2][7]. The vendor's clinical solution brochure includes clinical trial management functions such as reference ranges, visit/time point-based rules, kit production and distribution, specimen collection, data validation, contact management for clinical sites, and reporting and blinding rules [6]. STARLIMS also lists Dr Lal PathLabs as a customer testimonial source and describes Wyoming Public Health Laboratory's use of STARLIMS Public Health LIMS, a separate product [1][5]. These materials suggest a segment spanning clinical diagnostics, clinical trials, and biorepositories, but the vendor does not publish a customer count specific to the Clinical LIMS.

Clinisys describes GLIMS as suitable for private, hospital, specialist, and university laboratories, with genetics and HLA modules for specialized disciplines [9]. The vendor states that GLIMS Genetics Module offers flexible configuration for small laboratories or large, multi-site networked laboratories [10]. Clinisys also describes its broader Clinisys Laboratory Solution as cloud-based software serving small, single-site labs to expansive, multi-country networks [12]. The retrieved GLIMS materials emphasize European user feedback and IHE Connectathon participation, while the interfaces page lists US-based EHR and reference lab systems [9][11]. The geographic and segment emphasis differs from STARLIMS, but neither vendor provides a comparable breakdown of installed base by laboratory type.

Regulatory Statements and Unresolved Questions

STARLIMS states that its Clinical LIMS helps users comply with 21 CFR Part 11, ICH, GxP, HIPAA, IRB, CAP, CLIA, ISO 17025, and ISO 9001 [2]. The vendor also publishes ISO 9001 and ISO 27001 certification links [1]. These are vendor statements about compliance support, not certifications of the Clinical LIMS itself against each listed standard. STARLIMS does not state in the retrieved materials that the Clinical LIMS is FDA-cleared or approved as a medical device, and no US regulatory indication is documented. Buyers should treat the compliance list as a description of design intent and request evidence of applicable certifications for their specific jurisdiction and use case.

Clinisys does not provide a comparable regulatory standards list for GLIMS in the retrieved materials. The vendor documents IHE Connectathon test passage and describes HL7 protocol adherence [9][11]. Clinisys states that its Analytics Module does not diagnose, predict, or recommend treatment or clinical actions, nor provide patient-specific decision support [12]. This disclaimer applies to the Analytics Module within Clinisys Laboratory Solution, not necessarily to GLIMS itself. Neither vendor's public material resolves whether GLIMS or STARLIMS Clinical LIMS holds specific regulatory clearances in the US or other markets. Pricing, implementation timelines, and total cost of ownership are also absent from all retrieved sources.